- Home
- ARQT vs INOD Comparison
ARQT vs INOD Comparison
Compare ARQT & INOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- INOD
- Stock Information
- Founded
- ARQT 2016
- INOD 1988
- Country
- ARQT United States
- INOD United States
- Employees
- ARQT N/A
- INOD N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- INOD EDP Services
- Sector
- ARQT Health Care
- INOD Technology
- Exchange
- ARQT Nasdaq
- INOD Nasdaq
- Market Cap
- ARQT 1.1B
- INOD 1.2B
- IPO Year
- ARQT 2020
- INOD 1993
- Fundamental
- Price
- ARQT $12.68
- INOD $36.78
- Analyst Decision
- ARQT Strong Buy
- INOD Strong Buy
- Analyst Count
- ARQT 5
- INOD 4
- Target Price
- ARQT $17.00
- INOD $36.50
- AVG Volume (30 Days)
- ARQT 2.1M
- INOD 1.5M
- Earning Date
- ARQT 02-25-2025
- INOD 02-20-2025
- Dividend Yield
- ARQT N/A
- INOD N/A
- EPS Growth
- ARQT N/A
- INOD N/A
- EPS
- ARQT N/A
- INOD 0.62
- Revenue
- ARQT $138,708,000.00
- INOD $137,393,000.00
- Revenue This Year
- ARQT $209.03
- INOD $93.11
- Revenue Next Year
- ARQT $49.00
- INOD $34.30
- P/E Ratio
- ARQT N/A
- INOD $59.19
- Revenue Growth
- ARQT 182.84
- INOD 71.66
- 52 Week Low
- ARQT $3.11
- INOD $5.46
- 52 Week High
- ARQT $16.20
- INOD $55.17
- Technical
- Relative Strength Index (RSI)
- ARQT 43.06
- INOD 46.54
- Support Level
- ARQT $13.10
- INOD $32.54
- Resistance Level
- ARQT $14.36
- INOD $46.69
- Average True Range (ATR)
- ARQT 0.99
- INOD 3.01
- MACD
- ARQT -0.32
- INOD -0.70
- Stochastic Oscillator
- ARQT 1.95
- INOD 29.96
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About INOD Innodata Inc.
Innodata Inc is a digital services and solutions company. It provides technology and services to information products and online retail destinations. The company has three operating segments: Digital data solutions, Synodex, and Agility. It serves publishers, media and information companies, digital retailers, banks, insurance companies, government agencies, and other industries. Geographically, it operates in the United States, United Kingdom, Netherlands, Canada, and Europe.